Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Hyaluronate and Intra-articular Injection in Knee Osteoarthritis
NCT07033312Completed
- Sponsor
- Taichung Veterans General Hospital
- Start
- Apr 2023
- Primary completion
- Feb 2025
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of hyaluronic acid in knee osteoarthritis (OA) (2 arms), sponsored by Taichung Veterans General Hospital. Primary endpoint: Western Ontario and McMaster Universities Arthritis Index at 12 weeks. Started Apr 2023; status: completed.
02
Drugs
hyaluronic acid
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT07033312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07033312.